01 1Hangzhou Zhongmei Huadong Pharmaceutical
01 1DAPTOMYCIN
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-03-25
Pay. Date : 2019-08-26
DMF Number : 33671
Submission : 2019-09-25
Status : Active
Type : II
20
Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DAPTOMYCIN, with a corresponding US DMF Number 33671.
Remarkably, this DMF maintains an Active status since its submission on September 25, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 25, 2020, and payment made on August 26, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
